Austin Semaglutide Provider

Semaglutides work by mimicking the GLP-1 hormone, which helps regulate appetite and blood sugar levels. This leads to reduced hunger and increased feelings of fullness, making it easier to consume fewer calories and lose weight.

Semaglutide is typically recommended for individuals with a BMI of 30 or higher, or for those with a BMI of 27 or higher who have obesity-related health conditions such as hypertension or type 2 diabetes. A consultation with our team at Figura Medspa will determine if Semaglutide is right for you.

Semaglutide is administered as a once-weekly injection. Injections are administered in-clinic at one of our Austin locations at first to establish a baseline and increase safety and efficacy before transition to self administration for maintenance. Our team will provide detailed instructions on how to self-administer the injection at home, or you can choose to continue to have it administered at our medspa.

Common side effects of Semaglutide include nausea, diarrhea, and mild digestive discomfort, which often improve as your body adjusts to the medication. Our team will monitor your progress and make adjustments as needed to minimize side effects.

Weight loss with Semaglutide varies by individual, but many patients begin to see results within the first few weeks of treatment. Consistent use, along with healthy lifestyle changes, will maximize your results over time.

Tirzepatide and Semaglutide are both in the class of drugs known as incretin mimetics but there are some differences between the two. While semaglutide acts only on GLP-1 receptors, tirzepatide acts on both GLP-1 and GIP receptors. Both are effective treatments for weight loss, however responses to these medications may vary depending on the individual, as with any other medication. Our licensed medical team will work with you to find the option that is safest and most effective in achieving your weight-loss goals.

Ozempic and semaglutide are closely related but not synonymous. Semaglutide is the active ingredient in Ozempic, a prescription medication primarily used for the management of type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists, which work by mimicking the effects of the glucagon-like peptide-1 hormone. This helps to lower blood sugar levels by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying. While semaglutide is the compound that provides these benefits, Ozempic refers specifically to the branded formulation of the drug that patients receive, along with its specific dosing instructions and FDA-approved indications.

In addition to its use in diabetes management, semaglutide has gained attention for its application in weight management, particularly with the brand Wegovy, which delivers higher doses specifically designed for chronic weight management. This distinction is essential for patients and healthcare providers alike, as the different branding can lead to varied prescribing practices. Although the fundamental active ingredient remains the same, the formulations, dosing, and intended uses vary between Ozempic, Wegovy, and other semaglutide products. Therefore, while semaglutide is the core compound, Ozempic is one of its multiple applications, highlighting the importance of understanding these nuances when considering treatment options.

Wegovy and Semaglutide are often discussed interchangeably, but they represent different aspects of the same medication. Semaglutide is the active pharmaceutical ingredient that belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the action of the glucagon-like peptide-1 hormone in the body. This hormone plays a pivotal role in regulating appetite and glucose metabolism. Semaglutide is approved for multiple indications, including the treatment of type 2 diabetes (under the brand name Ozempic) and for weight management (under the brand name Wegovy). 

Wegovy, specifically, is the brand name used when Semaglutide is prescribed for chronic weight management in adults with obesity, or those who are overweight and have at least one weight-related condition, such as hypertension or type 2 diabetes. It comes in a higher dosage compared to Ozempic, reflecting the distinct focus on weight loss. Although both medications share the same active ingredient, they are marketed with different applications and dosages, emphasizing the importance of following a healthcare provider’s guidance when considering these treatments for diabetes or weight management.

Semaglutide, a medication primarily used for the management of type 2 diabetes and obesity, has gained considerable attention for its effectiveness. However, one key consideration for many prospective users is the cost associated with this treatment. On average, the price of semaglutide can range from $300 to $600 per month, depending on factors such as the dosage prescribed and the pharmacy from which it is purchased.

It’s important to note that these prices can vary widely based on geographic location, pharmacy pricing policies, and the presence of any manufacturer discounts or patient assistance programs

Ozempic & Wegovy (semaglutide) are a prescription medication primarily used to manage type 2 diabetes and, more recently, for weight management in certain individuals. To determine if you qualify for semaglutide, it’s important to consult a medical weight loss professional at Figura Medspa Austin who can assess your specific health needs and medical history. 

Before prescribing semaglutide, your doctor / medical weight loss professional will evaluate several factors, including your overall health, existing medical conditions, concurrent medications, and any allergies you may have. It’s essential to be upfront about your health history, as conditions like a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 can disqualify you from using this medication. Regular follow-up appointments will also be necessary to monitor your response to the drug and manage potential side effects.